Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
R. R. Kawalerski, M. Torrente Goncalves, C.-H. Pan…·L. F. Escobar-Hoyos
This study shows that phosphorylation of K17 promotes pancreatic cancer metastasis and shorter survival by disassembling keratin filaments and enabling nuclear translocation.
C.-H. Pan, N. Chaika, R. Tseng…·L. F. Escobar-Hoyos
This study identifies K17-mediated pyrimidine biosynthesis as a mechanism of chemoresistance in PDAC and shows that targeting DHODH with Brequinar enhances the efficacy of chemotherapy.
J. T. Polaski, D. B. Udy, L. F. Escobar-Hoyos…·R. K. Bradley
This study investigates UPF1 mutations in pancreatic adenosquamous carcinoma, finding they are likely non-pathogenic and not a common driver of the disease.
C.-H. Pan, Y. Otsuka, B. Sridharan…·K. R. Shroyer
This study identifies K17 as a biomarker for PDAC and shows that PPT, a microtubule inhibitor, is more effective against K17-expressing PDAC cells when combined with Gemcitabine.